AMGEN INC is 40.4x more valuable than Twist Bioscience Corp by market capitalization ($191.70 B vs $4.74 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TWST | AMGN |
|---|---|---|
| Market cap | $4.74 B | $191.70 B |
| US-listed rank | #1454 | #79 |
| Revenue (latest FY) | $376.57M | $36.75B |
| Net income (latest FY) | -$77.67M | $7.71B |
| Net margin | -20.6% | 21.0% |
| P/E (trailing FY) | - | 24.9 |
| SEC filings | 1,496 | 1,011 |
AMGEN INC is 40.4x more valuable than Twist Bioscience Corp by market capitalization ($191.70 B vs $4.74 B).
In their latest fiscal years, Twist Bioscience Corp reported $376.57M in revenue while AMGEN INC reported $36.75B.
Full pages: Twist Bioscience Corp and AMGEN INC, or browse the full rankings.